101 results  1 of 6 

1 Micturition symptoms in gynecologic cancer patients receiving paclitaxel and platinum-based chemotherapy regimen: a prospective study
Jongpeeti Wudtisan, Prapaporn Suprasert
Obstet Gynecol Sci.2023;66(1):34-41.   2023 January     DOI: http://dx.doi.org/10.5468/ogs.22241
      
2 Metastatic ameloblastoma with postoperative accelerated tumor growth treated with carboplatin and paclitaxel: a case report
Joo Un Park, Jae Wan Jung
Kosin Med J.2022;37(1):83-88.   Published online 2022 March 23     DOI: http://dx.doi.org/10.7180/kmj.21.030
      
3 Neurotoxicity of Paclitaxel and Rapamycin in a Rat Model with Transient Blood-Brain Barrier Opening
Won-Sang Cho, Jung Hoon Choi, O-Ki Kwon
J Korean Neurosurg Soc.2022;65(2):180-185.   Published online 2022 February 17     DOI: http://dx.doi.org/10.3340/jkns.2021.0077
      
4 Clinical Outcomes of Atherectomy Plus Drug-coated Balloon Versus Drug-coated Balloon Alone in the Treatment of Femoropopliteal Artery Disease
Jung-Joon Cha, Jae-Hwan Lee, Young-Guk Ko, Jae-Hyung Roh, Yong-Hoon Yoon, Yong-Joon Lee, Seung-Jun Lee, Sung-Jin Hong, Chul-Min Ahn, Jung-Sun Kim, Byeong-Keuk Kim, Donghoon Choi, Myeong-Ki Hong, Yangsoo Jang
Korean Circ J.2021;52(2):123-133.   Published online 2021 October 28     DOI: http://dx.doi.org/10.4070/kcj.2021.0246
      
5 A Real-World Efficacy of Nab-Paclitaxel Monotherapy in Metastatic Breast Cancer
Jung Sun Kim, Koung Jin Suh, Dae-Won Lee, Go-un Woo, Miso Kim, Se Hyun Kim, Han Suk Ryu, Kyung-Hun Lee, Tae-Yong Kim, Sae-Won Han, So Yeon Park, In Ae Park, Jee Hyun Kim, Seock-Ah Im
Cancer Res Treat.2022;54(2):488-496.   Published online 2021 August 13     DOI: http://dx.doi.org/10.4143/crt.2021.394
      
6 Multiple drug-coated balloons can be used effectively for peripheral arterial disease including long femoropopliteal lesions
Wongong Chu, Dong Hyun Kim, Sukyung Kwon, Je-hyung Park, Hyuk Jae Jung, Sang Su Lee
Ann Surg Treat Res.2021;101(2):120-128.   Published online 2021 July 29     DOI: http://dx.doi.org/10.4174/astr.2021.101.2.120
      
7 Anti-proliferative and apoptotic effects of hull-less pumpkin extract on human papillary thyroid carcinoma cell line
Mohammad Hadi Bahadori, Zoleikha Azari, Arash Zaminy, Sara Dabirian, Seyed Mojtaba Mehrdad, Bahman Jalali Kondori
Anat Cell Biol.2021;54(1):104-111.   Published online 2021 March 31     DOI: http://dx.doi.org/10.5115/acb.20.228
      
8 Real-World Clinical Outcomes and Prognostic Factors for Patients with Advanced Angiosarcoma Who Received Systemic Treatment
Changhee Park, Miso Kim, Yoonjin Kwak, Kyung Chul Moon, Se Hyun Kim, Bhumsuk Keam, Yu Jung Kim, Tae Min Kim, Dong-Wan Kim
Cancer Res Treat.2021;53(4):1195-1203.   Published online 2021 February 1     DOI: http://dx.doi.org/10.4143/crt.2020.1337
      
9 ATG5 knockout promotes paclitaxel sensitivity in drug-resistant cells via induction of necrotic cell death
Sung-Hee Hwang, Hojin Yeom, Michael Lee
Korean J Physiol Pharmacol.2020;24(3):233-240.   Published online 2020 May 1     DOI: http://dx.doi.org/10.4196/kjpp.2020.24.3.233
      
10 Clinical Outcomes of Second-Line Chemotherapy after Progression on Nab-Paclitaxel Plus Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma
Kyoungmin Lee, Kyunghye Bang, Changhoon Yoo, Inhwan Hwang, Jae Ho Jeong, Heung-Moon Chang, Dongwook Oh, Tae Jun Song, Do Hyun Park, Sang Soo Lee, Sung Koo Lee, Myung-Hwan Kim, Jin-hong Park, Kyu-pyo Kim, Baek-Yeol Ryoo
Cancer Res Treat.2020;52(1):254-262.   Published online 2019 July 9     DOI: http://dx.doi.org/10.4143/crt.2019.190
      
11 A Case of Recurrent Cervical Cancer Responded to Paclitaxel and Carboplatin Combination
Hyun Hoon Chung, Jae Weon Kim, Moon Hong Kim, Joo Won No, Noh Hyun Park, Yong Sang Song, Soon Beom Kang, Hyo Pyo Lee, Seong Il Kim, Taek Sang Lee
Korean J Gynecol Oncol Colposc.2000;11(3):336-342.   Published online 2019 March 13     DOI: http://dx.doi.org/10.3802/kjgoc.2000.11.3.336
      
12 Comparison Between Paclitaxel-Carboplatin and Paclitaxel-Cisplatin as a Combination Chemotherapy in Recurrent Ovarian Cancer
Hang Jo Yoo, Yong Man Kim, Hea Rim Lee, Mi Kyung Kim, Dong Heon Lee, Jong Hyeok Kim, Young Tak Kim, Jung Eun Mok, Joo Hyun Nam
Korean J Gynecol Oncol Colposc.2001;12(2):120-127.   Published online 2019 March 13     DOI: http://dx.doi.org/10.3802/kjgoc.2001.12.2.120
      
13 Taxol as Salvage Therapy in Patients with Recurrent Ovarian Carcinoma After First Line Chemotherapy
Do Hyung Kim, Sun Hwa Noh, Dong Hwi Kim, Un Dong Park
Korean J Gynecol Oncol Colposc.1998;9(2):163-167.   Published online 2019 March 13     DOI: http://dx.doi.org/10.3802/kjgoc.1998.9.2.163
      
14 The efficacy of paclitaxel based combination chemotherapy in recurrent endometrial cancer
Eun Sun Choi, Min Hyung Jung, Gin Young Ma, Soo Jung Lee, Dae Yeon Kim, Jong Hyeok Kim, Yong Man Kim, Young Tak Kim, Joo Hyun Nam, Jung Eun Mok
Korean J Gynecol Oncol.2005;16(2):163-168.   Published online 2019 March 12     DOI: http://dx.doi.org/10.3802/kjgo.2005.16.2.163
      
15 Identification of TACC3 (Transforming Acidic Coiled-Coil 3) as a novel target of paclitaxel-mediated tumor therapy in cervical cancer cells
Eun Kyoung Yim, Keun Ho Lee, Hee Jung Lee, Chan Joo Kim, Tae Chul Park, Soo Jong Um, Jong Sup Park
Korean J Gynecol Oncol.2005;16(3):229-241.   Published online 2019 March 12     DOI: http://dx.doi.org/10.3802/kjgo.2005.16.3.229
      
16 Development of a therapeutic method in the HPV-related cervical lesion using pH/temperature sensitive polymer spray formulation
Chan Joo Kim, Byeong Moon Jeong, Tae Woo Kim, Tae Heung Kang, Kyung Hee Noh, Myoung Ok Kim, Zae Young Ryoo, Hy Sook Kim, Jong Sup Park
Korean J Gynecol Oncol.2007;18(4):289-298.   Published online 2019 March 12     DOI: http://dx.doi.org/10.3802/kjgo.2007.18.4.289
      
17 The Response Rate of Carboplatin/Paclitaxel for the Platinum Sensitive Recurrent Ovarian Cancer Patients
Hye Jin Chang, Hee Sug Ryu, Yun Kyoung Lim, Se Hee Moon, Ki Hong Chang, Jung Pil Lee
Korean J Gynecol Oncol Colposc.2003;14(4):275-280.   Published online 2019 March 12     DOI: http://dx.doi.org/10.3802/kjgoc.2003.14.4.275
      
18 Incorporation of paclitaxel-based hyperthermic intraperitoneal chemotherapy in patients with advanced-stage ovarian cancer treated with neoadjuvant chemotherapy followed by interval debulking surgery: a protocol-based pilot study
Yong Jae Lee, Jung-Yun Lee, Min-Soo Cho, Eun Ji Nam, Sang Wun Kim, Sunghoon Kim, Young Tae Kim
J Gynecol Oncol.2019;30(1):e3.  Published online 2018 September 10     DOI: http://dx.doi.org/10.3802/jgo.2019.30.e3
      
19 Weekly versus 3-weekly paclitaxel in combination with carboplatin in advanced ovarian cancer: which is the optimal adjuvant chemotherapy regimen?
Matilda X. Lee, David SP Tan
J Gynecol Oncol.2018;29(6):e96.  Published online 2018 August 18     DOI: http://dx.doi.org/10.3802/jgo.2018.29.e96
      
20 Prediction of Acquired Taxane Resistance Using a Personalized Pathway-Based Machine Learning Method
Young Rae Kim, Dongha Kim, Sung Young Kim
Cancer Res Treat.2019;51(2):672-684.   Published online 2018 August 10     DOI: http://dx.doi.org/10.4143/crt.2018.137
      

 1 of 6